Similar Papers

Paper Title
Journal
Date
Author
Trial-in-progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC).
Hailey Kathryn Carroll ... Diarmaid Houlihan
Journal of Clinical Oncology | VOL. 39
Hailey Kathryn Carroll, et. al.Hailey Kathryn Carroll ... Diarmaid Houlihan
20 Jan 2021
Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)?
Neil Mehta ... Francis Y Yao
Gastroenterology | VOL. 151
Neil Mehta, et. al.Neil Mehta ... Francis Y Yao
27 Oct 2016
Treatment for Hepatocellular Carcinoma in South Asia
Subrat K Acharya
Journal of Clinical and Experimental Hepatology | VOL. 11
Subrat K AcharyaSubrat K Acharya
24 Sep 2021
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Riad Salem ... Robert J Lewandowski
Clinical Gastroenterology and Hepatology | VOL. 11
Riad Salem, et. al.Riad Salem ... Robert J Lewandowski
25 Jan 2013
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
Daniel J Landsburg ... Cameron J Turtle
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniel J Landsburg, et. al.Daniel J Landsburg ... Cameron J Turtle
09 Feb 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Ramya Ramaswami ... Chia-Ching Jackie Wang
Journal for ImmunoTherapy of Cancer | VOL. 13
Ramya Ramaswami, et. al.Ramya Ramaswami ... Chia-Ching Jackie Wang
06 Feb 2025
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Troels Holz Borch ... Inge Marie Svane
Journal for ImmunoTherapy of Cancer | VOL. 13
Troels Holz Borch, et. al.Troels Holz Borch ... Inge Marie Svane
06 Feb 2025
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
Michiel M Smeenk ... Willemijn S M E Theelen
Journal for ImmunoTherapy of Cancer | VOL. 13
Michiel M Smeenk, et. al.Michiel M Smeenk ... Willemijn S M E Theelen
06 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.